Galectin Therapeutics Inc.

Galectin Therapeutics Inc. - PE Ratioverified

GALT

Price:

$2.825

Market Cap:

$186.05M

Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disorders and various cancers. The company's flagship therapeutic agent is belapectin (GR-MD-02), an inhibitor of galectin-3, which is a complex polysaccharide polymer. This compound is currently undergoing Phase III clinical trials, assessing its effectiveness in treating liver scarring linked to fatty liver disease and non-alcoholic steatohepatitis (NASH) cirrhosis, alongside its potential for cancer treatment. Beyond belapectin, Galectin Therapeutics is progressing GM-CT-01 through preclinical stag...[Read more]

Industry

Biotechnology

IPO Date

2002-09-04

Stock Exchange

NASDAQ

Ticker

GALT

The PE Ratio as of June 2026 (TTM) for Galectin Therapeutics Inc. (GALT) is -6.89

According to Galectin Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.89. This represents a change of -20.37% compared to the average of -8.65 of the last 4 quarters.

Galectin Therapeutics Inc. (GALT) Historical PE Ratio (quarterly & annually)

How has GALT PE Ratio performed in the past?

The mean historical PE Ratio of Galectin Therapeutics Inc. over the last ten years is -4.95. The current -6.89 PE Ratio has changed 13.81% with respect to the historical average. Over the past ten years (40 quarters), GALT's PE Ratio was at its highest in in the December 2022 quarter at -0.55. The PE Ratio was at its lowest in in the September 2018 quarter at -20.50.

Quarterly (TTM)
Annual

Average

-4.95

Median

-4.72

Minimum

-9.80

Maximum

-1.34

Galectin Therapeutics Inc. (GALT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Galectin Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 440.97%

Maximum Annual PE Ratio = -1.34

Minimum Annual Increase = -56.33%

Minimum Annual PE Ratio = -9.80

Quarterly (TTM)
Annual
YearPE RatioChange
2025-8.67410.59%
2024-1.70-24.33%
2023-2.2429.04%
2022-1.74-56.33%
2021-3.98-27.14%
2020-5.46-25.50%
2019-7.33-25.17%
2018-9.8034.97%
2017-7.26440.97%
2016-1.34-32.07%

Galectin Therapeutics Inc. (GALT) Average PE Ratio

How has GALT PE Ratio performed in the past?

The current PE Ratio of Galectin Therapeutics Inc. (GALT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-4.20

5-year avg

-3.67

10-year avg

-4.95

Galectin Therapeutics Inc. (GALT) PE Ratio vs. Peers

How is GALT’s PE Ratio compared to its peers?

Galectin Therapeutics Inc.’s PE Ratio is greater than I-Mab (-17.26), greater than DiaMedica Therapeutics Inc. (-8.24), greater than Design Therapeutics, Inc. (-10.37), less than Rocket Pharmaceuticals, Inc. (-1.79), less than Aura Biosciences, Inc. (-3.58), greater than Alpha Tau Medical Ltd. (-14.60), less than enGene Holdings Inc. (-1.30), less than LB Pharmaceuticals Inc Common Stock (-1.40), less than Altimmune, Inc. (-2.90), less than Quantum-Si incorporated (-1.94),

Build a custom stock screener for Galectin Therapeutics Inc. (GALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galectin Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galectin Therapeutics Inc. (GALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galectin Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Galectin Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Galectin Therapeutics Inc. (GALT)?

What is the highest PE Ratio for Galectin Therapeutics Inc. (GALT)?

What is the 3-year average PE Ratio for Galectin Therapeutics Inc. (GALT)?

What is the 5-year average PE Ratio for Galectin Therapeutics Inc. (GALT)?

How does the current PE Ratio for Galectin Therapeutics Inc. (GALT) compare to its historical average?